1beta-Hydroxy-beta-eudesmol

Details

Top
Internal ID ba8f2353-83c9-4425-9ab4-b2bb5d6b4043
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids > Eudesmane, isoeudesmane or cycloeudesmane sesquiterpenoids
IUPAC Name (1R,4aS,6R,8aR)-6-(2-hydroxypropan-2-yl)-8a-methyl-4-methylidene-1,2,3,4a,5,6,7,8-octahydronaphthalen-1-ol
SMILES (Canonical) CC12CCC(CC1C(=C)CCC2O)C(C)(C)O
SMILES (Isomeric) C[C@@]12CC[C@H](C[C@H]1C(=C)CC[C@H]2O)C(C)(C)O
InChI InChI=1S/C15H26O2/c1-10-5-6-13(16)15(4)8-7-11(9-12(10)15)14(2,3)17/h11-13,16-17H,1,5-9H2,2-4H3/t11-,12+,13-,15-/m1/s1
InChI Key MQOLOUZWNJHZLN-QVHKTLOISA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H26O2
Molecular Weight 238.37 g/mol
Exact Mass 238.193280068 g/mol
Topological Polar Surface Area (TPSA) 40.50 Ų
XlogP 2.20
Atomic LogP (AlogP) 2.89
H-Bond Acceptor 2
H-Bond Donor 2
Rotatable Bonds 1

Synonyms

Top
83217-89-4
(1R,4aS,6R,8aR)-6-(2-hydroxypropan-2-yl)-8a-methyl-4-methylidene-1,2,3,4a,5,6,7,8-octahydronaphthalen-1-ol
4(15)-Eudesmene-1beta,11-diol
AKOS032962698

2D Structure

Top
2D Structure of 1beta-Hydroxy-beta-eudesmol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9968 99.68%
Caco-2 + 0.6119 61.19%
Blood Brain Barrier - 0.6000 60.00%
Human oral bioavailability - 0.5429 54.29%
Subcellular localzation Mitochondria 0.5452 54.52%
OATP2B1 inhibitior - 0.8514 85.14%
OATP1B1 inhibitior + 0.9040 90.40%
OATP1B3 inhibitior + 0.8850 88.50%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.6500 65.00%
BSEP inhibitior - 0.7562 75.62%
P-glycoprotein inhibitior - 0.9376 93.76%
P-glycoprotein substrate - 0.8845 88.45%
CYP3A4 substrate + 0.6190 61.90%
CYP2C9 substrate - 0.5811 58.11%
CYP2D6 substrate - 0.7340 73.40%
CYP3A4 inhibition - 0.7473 74.73%
CYP2C9 inhibition - 0.8889 88.89%
CYP2C19 inhibition - 0.6823 68.23%
CYP2D6 inhibition - 0.9411 94.11%
CYP1A2 inhibition - 0.8202 82.02%
CYP2C8 inhibition - 0.7680 76.80%
CYP inhibitory promiscuity - 0.7637 76.37%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.8800 88.00%
Carcinogenicity (trinary) Non-required 0.6132 61.32%
Eye corrosion - 0.9883 98.83%
Eye irritation - 0.6298 62.98%
Skin irritation + 0.5231 52.31%
Skin corrosion - 0.9580 95.80%
Ames mutagenesis - 0.8800 88.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6281 62.81%
Micronuclear - 0.9800 98.00%
Hepatotoxicity + 0.6375 63.75%
skin sensitisation + 0.6438 64.38%
Respiratory toxicity - 0.5111 51.11%
Reproductive toxicity + 0.8778 87.78%
Mitochondrial toxicity + 0.7875 78.75%
Nephrotoxicity - 0.7711 77.11%
Acute Oral Toxicity (c) III 0.8057 80.57%
Estrogen receptor binding - 0.5164 51.64%
Androgen receptor binding - 0.5431 54.31%
Thyroid receptor binding - 0.5355 53.55%
Glucocorticoid receptor binding + 0.6463 64.63%
Aromatase binding - 0.7296 72.96%
PPAR gamma - 0.7543 75.43%
Honey bee toxicity - 0.8423 84.23%
Biodegradation - 0.5750 57.50%
Crustacea aquatic toxicity + 0.6500 65.00%
Fish aquatic toxicity + 0.9920 99.20%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 98.51% 97.25%
CHEMBL1871 P10275 Androgen Receptor 95.36% 96.43%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 93.06% 91.11%
CHEMBL1977 P11473 Vitamin D receptor 92.45% 99.43%
CHEMBL1994 P08235 Mineralocorticoid receptor 89.22% 100.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 87.08% 97.09%
CHEMBL5888 Q99558 Mitogen-activated protein kinase kinase kinase 14 83.80% 100.00%
CHEMBL2996 Q05655 Protein kinase C delta 83.47% 97.79%
CHEMBL5608 Q16288 NT-3 growth factor receptor 83.44% 95.89%
CHEMBL3351 Q13085 Acetyl-CoA carboxylase 1 81.46% 93.04%

Cross-Links

Top
PubChem 13969455
NPASS NPC163567
LOTUS LTS0162886
wikiData Q105170145